Header
Header
Article

Resolution of Heart Failure Inflammation


Editorial

. 2022 Jun 27;7(6):561-562.


doi: 10.1016/j.jacbts.2022.03.016.


eCollection 2022 Jun.

Affiliations

Item in Clipboard

Editorial

Magnus Bäck.


JACC Basic Transl Sci.


.

No abstract available


Keywords:

NRF2; SERCA2A; calcium handling; myocarditis; pro-resolving mediators.

Conflict of interest statement

Dr Bäck is an awardee of the Gutenberg Chair of Excellence from the Région Grand Est and the Eurométropole de Strasbourg and supported by the Swedish Research Council (grant number 2019-01486), the Swedish Heart and Lung Foundation (grant number 20210560), and the King Gustaf V and Queen Victoria Freemason Foundation.

Figures



Graphical abstract

Comment on

  • doi: 10.1016/j.jacbts.2022.01.009

References

    1. Pirault J., Bäck M. Lipoxin and resolvin receptors transducing the resolution of inflammation in cardiovascular disease. Front Pharmacol. 2018;9:1273.



      PMC



      PubMed

    1. Arnardottir H., Thul S., Pawelzik S.C., et al. The resolvin D1 receptor GPR32 transduces inflammation resolution and atheroprotection. J Clin Invest. 2021;131(24)



      PMC



      PubMed

    1. Val-Blasco A., Prieto P., Jaén R.I., et al. Specialized proresolving mediators protect against experimental autoimmune myocarditis by modulating Ca2+ handling and NRF2 activation. J Am Coll Cardiol Basic Trans Science. 2022;7(6):544–560.

    1. Biasco L., Klersy C., Beretta G.S., et al. Comparative frequency and prognostic impact of myocardial injury in hospitalized patients with COVID-19 and influenza. Eur Heart J Open. 2021;1(3) doi: 10.1093/ehjopen/oeab025.



      DOI

    1. Blanco-Dominguez R., Sanchez-Diaz R., de la Fuente H., et al. A novel circulating microRNA for the detection of acute myocarditis. N Engl J Med. 2021;384:2014–2027.



      PMC



      PubMed



Source link

Back to top button